In an effort to control the quality of medicinal products, the government has brought out the Indian Pharmacopoeia, 2007, which lays down the standards for drugs produced or marketed in India. The standards of this pharmacopoeia are authoritative, legally enforceable and intended to help in the inspection and licensing of manufacturing and distribution of drugs and pharmaceuticals. It has been prepared in accordance with the principles and designed plan decided by the scientific body of the Indian Pharmacopoeia Commission. In addition to the past practices of requesting for comments, the contents of revised appendices and monographs have been publicised on the website of the commission for collecting comments from various institutions and organisations. All the feedback and inputs have been reviewed by the relevant expert committee to ensure the feasibility and practicability of the standards and methods revised in this edition of the Pharmacopoeia, as well as the principle of openness, justice and fairness. The document, released by Union Health Minister Anbumani Ramadoss, has been published in three volumes. It is said that it would also play a vital role in initiating new prospective for improving the quality of medicines and accelerate development of pharma sector in India.